tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

ADMA Biologics Announces Board Resignations and Appointments

ADMA Biologics Announces Board Resignations and Appointments

Meet Your ETF AI Analyst

An update from ADMA Biologics ( (ADMA) ) is now available.

Bryant E. Fong has resigned from ADMA Biologics’ Board of Directors to focus on his roles at Biomark Capital Fund and Stonepine Capital Management, with no disagreements reported. Young T. Kwon, PhD steps in as Chairman of the Audit Committee, alongside new committee members Steven A. Elms and Alison C. Finger, signaling a strategic reshuffle in the company’s governance.

Find detailed analytics on ADMA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1